BBS-Bioactive Bone Substitutes (OHEL:BONEH) FCF Margin % : 0.00% (As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is BBS-Bioactive Bone Substitutes FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. BBS-Bioactive Bone Substitutes's Free Cash Flow for the six months ended in Dec. 2023 was €-1.49 Mil. BBS-Bioactive Bone Substitutes's Revenue for the six months ended in Dec. 2023 was €0.00 Mil. Therefore, BBS-Bioactive Bone Substitutes's FCF Margin % for the quarter that ended in Dec. 2023 was 0.00%.

As of today, BBS-Bioactive Bone Substitutes's current FCF Yield % is -34.54%.

The historical rank and industry rank for BBS-Bioactive Bone Substitutes's FCF Margin % or its related term are showing as below:

OHEL:BONEH's FCF Margin % is not ranked ^*
in the Medical Devices & Instruments industry.
Industry Median: -7.07
* Ranked among companies with meaningful FCF Margin % only.

BBS-Bioactive Bone Substitutes FCF Margin % Historical Data

The historical data trend for BBS-Bioactive Bone Substitutes's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BBS-Bioactive Bone Substitutes FCF Margin % Chart

BBS-Bioactive Bone Substitutes Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

BBS-Bioactive Bone Substitutes Semi-Annual Data
	Dec15	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
FCF Margin %	Get a 7-Day Free Trial											-	-	-	-	-

Competitive Comparison of BBS-Bioactive Bone Substitutes's FCF Margin %

For the Medical Devices subindustry, BBS-Bioactive Bone Substitutes's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BBS-Bioactive Bone Substitutes's FCF Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, BBS-Bioactive Bone Substitutes's FCF Margin % distribution charts can be found below:

* The bar in red indicates where BBS-Bioactive Bone Substitutes's FCF Margin % falls into.

BBS-Bioactive Bone Substitutes FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

BBS-Bioactive Bone Substitutes's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-2.923	/	0
	=	%

BBS-Bioactive Bone Substitutes's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-1.492	/	0
	=	%

BBS-Bioactive Bone Substitutes FCF Margin % Related Terms

Thank you for viewing the detailed overview of BBS-Bioactive Bone Substitutes's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

BBS-Bioactive Bone Substitutes (OHEL:BONEH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » BBS-Bioactive Bone Substitutes PLC (OHEL:BONEH) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Kiviharjunlenkki 6, Oulu, FIN, 90220

Website

http://www.bbs-artebone.fi

BBS-Bioactive Bone Substitutes PLC is a health technology company, that develops, designs, and manufactures bioactive bone-graft substitute implants. Its ortho-biological product ARTEBONE, which is based on tricalcium phosphate and a natural spectrum of bone proteins has the capability of bone regeneration.

BBS-Bioactive Bone Substitutes (OHEL:BONEH) Headlines

No Headlines